Rondo Therapeutics
Hayward
About Rondo Therapeutics
Rondo Therapeutics is a therapeutic antibody discovery and development that creates novel bispecific antibodies that activate the immune system to fight cancer. The company was founded in 2021 and is headquartered in Hayward, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $67.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2022)
- Website: rondotx.com
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/rondo-therapeutics-66635 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.